Learn how your body works and how new medical breakthroughs may affect you with the Mini-Med Series.
Held on Mondays beginning Oct. 8, the series will be composed of five sessions led by Case Western Reserve University faculty members.
Drew Adams, the Thomas F. Peterson, Jr. Professor of Novel Therapeutics and a Mount Sinai Scholar, will open the series with a session titled “Moving Scientific Breakthroughs Toward Therapies: New Opportunities for Drug Development at Case Western Reserve University.”
This session will be held Monday, Oct. 8, from 6:30 to 8:30 p.m. at the Tinkham Veale University Center.
The series schedule will be:
- Oct. 8—“Moving Scientific Breakthroughs Toward Therapies: New Opportunities for Drug Development at Case Western Reserve University” by Adams
- Oct. 15—“The Future of Cancer Centers” by Stan Gerson, director of the Case Comprehensive Cancer Center and director of the National Center for Regenerative Medicine
- Oct. 22—“Disordered Breathing and Sleep Apnea” by Kingman Strohl, chief of pulmonary, critical care and sleep medicine in the Department of Medicine
- Oct. 29—“Lymphoma and Leukemia” by Marcos de Lima, professor of medicine
- Nov. 5—“Lung Cancer” by Afshin Dowlati, the Rosalie and Morton Cohen Chair in Lung Cancer, the Lucile and the Robert Gries Endowed Director of the Center for Cancer Drug Development
Participants do not need a background in math or science.
Space is limited.
The full series costs $87 for members of the Siegal Lifelong Learning Program and $102 for nonmembers. Individual sessions cost $20 for members and $25 for nonmembers.